The Society of Thoracic Surgeons Congenital Heart Surgery Database is the largest congenital and pediatric cardiac surgical clinical data registry in the world. It is the platform for all activities of The Society of Thoracic Surgeons related to the analysis of outcomes and the improvement of quality in this subspecialty. This article summarizes current aggregate national outcomes in congenital and pediatric cardiac surgery and reviews related activities in the areas of quality measurement, performance improvement, and transparency. The reported data about aggregate national outcomes are exemplified by an analysis of 10 benchmark operations performed from January 2011 to December 2014 and documenting overall discharge mortality (interquartile range among programs with more than 9 cases): offbypass coarctation, 1.0% (0.0% to 0.9%); ventricular septal defect repair, 0.7% (0.0% to 1.1%); tetralogy of Fallot repair, 1.0% (0.0% to 1.7%); complete atrioventricular canal repair, 3.2% (0.0% to 6.5%); arterial switch operation, 2.7% (0.0% to 5.6%); arterial switch operation plus ventricular septal defect, 5.3% (0.0% to 6.7%); Glenn/hemiFontan, 2.1% (0.0% to 3.8%); Fontan operation, 1.4% (0.0% to 2.4%); truncus arteriosus repair, 9.6% (0.0 % to 11.8%); and Norwood procedure, 15 .6% (10.0% to 21.4%).
(Ann Thorac Surg 2016;101:850-62) Ó 2016 by The Society of Thoracic Surgeons T he Society of Thoracic Surgeons Congenital Heart Surgery Database (STS CHSD) was founded in 1994 to support quality improvement and patient safety in pediatric and congenital cardiothoracic surgery [1] [2] [3] . The STS CHSD is now the largest congenital and pediatric cardiac surgical clinical data registry in the world, containing records of 354,846 operations as of September 25, 2015 . These data are the foundation for assessment of performance (through benchmarking and comparison of individual programmatic outcomes to national aggregate data), sophisticated risk-adjustment models [4] [5] [6] [7] , quality improvement initiatives, research, voluntary public reporting [8] [9] [10] [11] , development of reimbursement strategies, and governmental and regulatory collaborations. This article is the first in a series of annual reports summarizing current national aggregate congenital and pediatric cardiac surgical outcomes and detailing quality measurement and performance improvement activities based on the STS CHSD during the past year [12, 13] .
Overview of STS CHSD
Collection of detailed clinical data and feedback of riskadjusted nationally benchmarked results to participating cardiac surgical programs are the primary functions of the STS CHSD [13] . A participant in the STS CHSD is typically a hospital cardiac surgery program, a practice group of cardiothoracic surgeons, or uncommonly, an individual surgeon. Data are submitted to the STS data warehouse and analytical center at the Duke Clinical Research Institute (DCRI). The DCRI harvests the data two times each year, and Feedback Reports are disseminated every 6 months to each STS CHSD participant. These Feedback Reports facilitate internal quality assurance and quality improvement by presenting data about the risk factors and outcomes of the individual participant in comparison with national benchmark data.
The spectrum of individual congenital cardiac malformations is broad, and the variety of types of cardiac disease affecting individuals early in life is large. Consequently, to collect relevant data, a congenital cardiac surgical database must account for nearly 200 individual diagnoses and a roughly comparable number of distinct types of therapeutic interventions. To maintain clinical relevance with evolving surgical practice, data elements in STS CHSD undergo periodic revision to clarify existing variables, harmonize definitions with related national and international databases, add new variables of interest, and remove irrelevant ones. These revisions are performed on a 3-year cycle.
As of September 25, 2015, the STS CHSD included 122 participants comprising 376 surgeons from 39 states in the United States and from four other countries. Of the 354,846 cumulative worldwide operations included in the STS CHSD, 344,202 have been performed in the United States. The 113 participants in the United States represent 124 hospitals. The report of the 2010 STS Congenital Heart Surgery Practice and Manpower Survey, undertaken by the STS Workforce on Congenital Heart Surgery, estimates that 125 hospitals perform pediatric cardiac surgery in the United States, and eight hospitals perform pediatric cardiac surgery in Canada [14] . Therefore, more than 95% of hospitals that perform pediatric heart surgery in the United States participate in the STS CHSD, and the patient level penetration is even higher. These data suggest that nearly all pediatric cardiac operations performed in the United States are captured in the STS CHSD.
Assessing Outcomes With STS CHSD
To perform meaningful multiinstitutional analyses of outcomes, any database should incorporate the following seven essential elements [15] [16] [17] : (1) use of a common language and nomenclature; (2) an established uniform core dataset for collection of information; (3) incorporation of a mechanism to evaluate and account for case complexity; (4) availability of a mechanism to assure and verify the completeness and accuracy of the data collected; (5) collaboration between medical and surgical subspecialties; (6) standardization of protocols for lifelong follow-up; and (7) incorporation of strategies for quality assessment and quality improvement. The STS CHSD has made important advances in six of these elements; however, STS CHSD has not yet developed strategies for longitudinal follow-up beyond discharge from the hospital and 30 days after surgery.
The International Pediatric and Congenital Cardiac Code (IPCCC) [18, 19] The IPCCC, and the common minimum database data set created by the International Congenital Heart Surgery Nomenclature and Database Project of STS and ECHSA/ EACTS, are now utilized by ECHSA/EACTS CHSD, STS CHSD, and the Japan Congenital Cardiovascular Surgery Database (JCCVSD). The combined dataset of STS CHSD, ECHSA/EACTS CHSD, and JCCVSD contains data from more than 500,000 pediatric and congenital cardiac operations performed beginning in 1998, all coded with the ECHSA/EACTS-STS-derived version of the IPCCC, and all coded with identical data specifications.
Three major multiinstitutional efforts have classified and stratified congenital cardiac surgical operations on the basis of procedural complexity or risk [20] [21] [22] The RACHS-1 and Aristotle Basic Complexity scores were developed at a time when limited multiinstitutional clinical data were available, and therefore were based in a large part on subjective probability (expert opinion) [20] . The STAT Mortality Categories [21, 22] represent the first empirically based tool for risk stratification of congenital and pediatric cardiac operations. The STAT Mortality Score and Categories were developed from an analysis of 77,294 operations entered into the ECHSA/EACTS CHSD (33,360 operations) and STS CHSD (43,934 patients) between 2002 and 2007. Procedure-specific mortality rate estimates were calculated using a Bayesian model that adjusted for small denominators. Operations were sorted by increasing risk and grouped into five categories (the STS-EACTS Congenital Heart Surgery Mortality Categories) that were designed to be optimal with respect to minimizing within-category variation and maximizing between-category variation. The STS and ECHSA/EACTS have transitioned from the primary use of Aristotle Score and RACHS-1 methodology to the primary use of the STAT Mortality Categories for three reasons: (1) the STAT Mortality Score was developed primarily based on objective data whereas RACHS-1 and Aristotle were developed based primarily on expert opinion (subjective probability); (2) the STAT Mortality Score allows for classification of more operations than RACHS-1 or Aristotle; and (3) the STAT Mortality Score has a higher c-statistic than RACHS-1 or Aristotle.
Collaborative efforts involving ECHSA/EACTS and STS aim to enhance mechanisms to verify the completeness and accuracy of the data in the databases [23] . A combination of three strategies may ultimately be required to allow for optimal verification of data: (1) intrinsic data verification (designed to rectify inconsistencies of data and missing elements of data); (2) site visits with ''source data verification'' (in other words, verification of the data at the primary source of the data); and (3) external verification of the data from independent databases or registries (such as governmental death registries).
Data quality in the STS CHSD is evaluated through intrinsic data verification by DCRI (including identification and correction of missing or out of range values and inconsistencies across fields). In addition to intrinsic data verification by DCRI, each year approximately 10% of participants are randomly selected for audits of their center, in accordance with their STS CHSD participation agreement. The audit is designed to complement the internal quality controls, with an overall objective of maximizing the integrity of the data in STS CHSD by examining the completeness and accuracy of the data. The STS has selected Telligen (http://www. telligen.com/) to perform these independent, external audits of STS CHSD. As the state of Iowa's Medicare quality improvement organization, Telligen partners with health care professionals to assure high-quality, costeffective health care. As a quality improvement organization, Telligen is compliant with the Health Insurance Portability and Accountability Act and performs audits adhering to strict security policies. Additionally, an experienced STS congenital heart surgeon volunteer leader participates in each audit.
In the STS CHSD, the audit process includes the following: (1) completion of the STS data collection questionnaire and review of responses with the primary data contact, data manager, or other relevant personnel;
(2) review of the data collection process and documentation to determine case eligibility for submission to STS CHSD; (3) comparison of facility operative case logs with cases submitted to STS CHSD; (4) data abstraction (from original source documents) of records of congenital and pediatric heart surgery randomly selected by DCRI; (5) data abstractions of all operative mortality cases for the preceding calendar year (the calendar year of the audit); (6) summary conference with the surgeon representative, primary data contact, data manager, or other relevant personnel to discuss general trends in data collection and submission processes; and (7) final written summary report that is produced for each audit. This summary report is reviewed and approved by the STS, and delivered to the STS CHSD participant. The summary report is the conclusion as well as the memorialization of the participant's audit process.
In 2013, the STS CHSD audit included documentation of the following rates of completeness and accuracy for the specified fields of data [13] : (1) primary procedure (completeness ¼ 100%, accuracy ¼ 98.7%); and (2) mortality status at hospital discharge (completeness ¼ 100%, accuracy ¼ 98.8%).
Under the leadership of the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease, further collaborative efforts are ongoing between congenital and pediatric cardiac surgeons and other subspecialties, including pediatric cardiac anesthesiologists through the Congenital Cardiac Anesthesia Society, pediatric cardiac intensivists through the Pediatric Cardiac Intensive Care Society, and pediatric cardiologists through the Joint Council on Congenital Heart Disease, the American College of Cardiology, and the Association for European Pediatric Cardiology [24] . This multidisciplinary collaboration reflects a recognition that for purposes of quality assessment and quality improvement it is essential that analysis of outcomes move beyond a focus solely on mortality. It must encompass longer term follow-up, including cardiac and noncardiac morbidities, and importantly, those morbidities affecting health-related quality of life. Methodologies must be implemented in these databases to allow uniform, protocol-driven, and meaningful long-term follow-up and quality improvement.
Measuring Quality With STS CHSD
The STS CHSD is increasingly used to document variation in outcomes [25, 26] and measure quality [17, 26] . Funnel plots may be used to demonstrate this variation in outcome and to enable centers to recognize their status as outliers in performance ( Fig 1) [25, 26] . In a funnel plot of programmatic mortality, the x-axis is the volume of operations each individual center (ie, each individual program or STS CHSD participant) and the y-axis is mortality. A horizontal dashed line depicts aggregate mortality. Dashed lines depicting exact 95% binomial prediction limits are overlaid to make a funnel plot. Squares represent the number of cases and mortality before discharge for each program [25, 26] . Survival after surgery can also be displayed with variable life-adjusted display charts, which indicate the cumulative difference in observed minus expected survival against the cumulative number of cases performed [27] . Quality improvement initiatives can be initiated in low-performing centers, and best practices can be identified by studying structure and processes of care at high-performing centers.
The STS has collaborated with the Congenital Heart Surgeons' Society (CHSS) to develop and endorse metrics to assess the quality of care delivered to patients with pediatric and congenital cardiac disease [28] . Table 1 presents 21 quality measures for congenital and pediatric cardiac surgery that were developed and approved by STS and endorsed by CHSS. These quality measures are organized according to Donabedian's triad of structure, process, and outcome [29] . It is hoped that these quality measures can aid in congenital and pediatric cardiac surgical quality assessment and quality improvement initiatives. These initiatives will take on added importance as the public reporting of cardiac surgery performance becomes more common [8] [9] [10] [11] .
Aggregate North American Outcomes in Congenital and Pediatric Cardiac Surgery
Aggregate outcomes, as summarized in this section, are based on data collected in the STS CHSD for all operations performed from January 1, 2011, to December 31, 2014, inclusive, and presented in the 2015 Spring Harvest Feedback Report [13] . The outcomes in this report are based on the data elements specified in the current versions of the data collection instrument (versions 3.0 and 3.22, which went live on January 1, 2010, and January 1, 2014, respectively), and are presented using only data from centers in North America. Table 2 reports aggregate outcomes of risk-stratified operations in the STS CHSD during the last 4 years (January 2011 to December 2014), with the endpoints of operative mortality and postoperative length of stay. Table 3 reports unadjusted aggregate outcomes for current benchmark operations in the STS CHSD, also during the last 4 years (January 2011 to December 2014), and also with the endpoints of operative mortality and postoperative length of stay.
Operative mortality is defined in all STS databases as (1) all deaths, regardless of cause, occurring during the hospitalization in which the operation was performed, even if after 30 days (including patients transferred to other acute care facilities); and (2) all deaths, regardless of cause, occurring after discharge from the hospital but before the end of the 30th postoperative day [30, 31] .
Beginning with the Spring 2014 STS CHSD Feedback Report, the STS CHSD Task Force now uses the field "mortality status at database discharge" rather than the field "mortality status at hospital discharge" when calculating operative mortality. This field, "mortality status at database discharge," is now used in combination with the field "status at 30 days after surgery" to arrive at a determination of operative mortality. Similarly, beginning with the Spring 2014 STS CHSD Feedback Report, the STS CHSD Task Force now uses the field "date of database discharge" rather than the field "date of hospital discharge" when calculating length of stay. This change in reporting was implemented to ensure accurate reporting of outcomes for patients who are transferred to another acute care facility or chronic care facility after undergoing surgery at a participating center. The definitions of the fields "mortality status at database discharge" and "date of database discharge" are based on the three rules described in Table 4 [30, 32] .
Quality Measurement in Congenital and Pediatric Cardiac Surgery
Clinical registries can provide practitioners with accurate and timely feedback of their own outcomes and can benchmark these outcomes to regional, national, or even international aggregate data [25, 26] . Clinical registries, therefore, represent a foundational tool in the following interrelated processes: (1) measuring the outcomes of medical and surgical practices; (2) developing evidence for best medical and surgical practices; (3) providing actionable feedback to clinicians; and (4) improving quality of care and outcomes.
The ultimate goal of clinical registries is to improve quality of care and outcomes. Clinical registries have been used to create standardized measures of quality that have been endorsed by multiple professional medical societies and the National Quality Forum (NQF [http:// www.qualityforum.org/]). Compliance with these measures and the public reporting of these measures should lead to improvements in the overall quality of care delivered to our patients [8] [9] [10] [11] .
The STS has developed four pediatric and congenital quality measures that are endorsed by NQF for quality improvement (both quality improvement internal to the specific organization and quality improvement with benchmarking [benchmarking external to the organization]) and public reporting ( Table 5) .
Risk-adjusted operative mortality for pediatric and congenital heart surgery (NQF Measure Number 2683 -see Table 5 ) is reported using the 2014 STS CHSD Mortality Risk Model, which facilitates description of operative mortality adjusted both for procedural factors and for patient level factors. The 2014 STS CHSD Mortality Risk Model adjusts for the variables listed in Table 6 . This 
Transparency and Public Reporting of National Outcomes in Congenital and Pediatric Cardiac Surgery
Health care is embarking on a new era of increased transparency [8] [9] [10] [11] , and the STS has been a leader in this movement. In January 2015, it began to publicly report outcomes of pediatric and congenital cardiac surgery using the STS CHSD Mortality Risk Model (http://www. sts.org/quality-research-patient-safety/sts-public-reportingonline) [4] [5] [6] [7] . For all STS CHSD participants who consent to participate in voluntary public reporting, STS public reporting online reports: (1) the overall operative mortality rate for each STS CHSD participant over a 4year period for all ages; and (2) the operative mortality rate for each STS CHSD participant over a 4-year period for all ages for each of the five STAT Mortality Categories. The STS public reporting online also includes the following data to provide a clear summary of the operative mortality of an STS CHSD participant: NUMBER/ELIGIBLE. This column of data presents a fraction with the numerator representing the number of observed patient deaths and the denominator representing the OBSERVED. This column of data presents the observed rate of operative mortality as a percentage. This percentage is calculated by dividing the number of observed deaths by the total number of eligible patients included in the calculation.
EXPECTED. This column of data presents the expected operative mortality rate as a percentage. The 2014 STS CHSD Mortality Risk Model is used to estimate the number of expected patient deaths when considering the actual case mix of a given STS CHSD participant (ie, the mix of patients treated as defined by all the variables listed in Table 6 ). It is important to note that incomplete or inaccurate submission of data related to the risk factors listed in Table 6 will result in an inaccurate estimation of expected mortality. The definitions of the fields "mortality status at database discharge" and "date of database discharge" are based on the following three rules [30, 32] : 1. For patients admitted from home, the date of database discharge and determination of mortality status at database discharge are predicated on the occurrence of one of the following three options: a. The patient dies. b. The patient is discharged to home. c. The patient survives in a chronic care facility for 6 postoperative months (ie, 183 postoperative days in the chronic care facility). If the patient survives in a chronic care facility for 6 postoperative months, the patient is then assigned a date of database discharge that is the date when the patient is in the chronic care facility for 183 days.
The mortality status at database discharge field should then be coded as "alive." (If an institution does not utilize a chronic care facility and instead keeps these chronic patients in house, this institution can apply this rule whenever one of their patients survives for 6 postoperative months (ie, 183 postoperative days) after being designated as having "chronic care status" within their own institution.) 2. For patients admitted from (ie, transferred from) a chronic care facility where they chronically reside, they must be either dead or discharged either to home or to a chronic care facility before completing the mortality status at database discharge and date of database discharge fields are completed. (If a patient was admitted from [ie, transferred from] a chronic care facility, then the chronic care facility is the "equivalent of home" for this patient for this admission.) 3. For patients admitted from (ie, transferred from) another acute care facility, rule number 1 above applies if they lived at home before their admission to the transferring acute care facility. For patients transferred from another acute care facility, rule number 2 above applies if they lived in a chronic care facility before their admission to the transferring acute care facility. If the CI is very wide, this means that we have less certainty regarding the true underlying adjusted operative mortality rate of the STS CHSD participant, usually because of small sample size. In general, the width of the CI decreases as the number of patients included in the calculation increases. The STS uses indirect standardization to calculate the expected rates of mortality and AMR. It is a fact that virtually all methods for profiling risk-adjusted health care outcomes use indirect standardization rather than direct standardization, because the latter is not feasible when numerous risk factors are included. The results from indirectly standardized analyses should not be used to directly compare one program with another. Rather, expected rates of mortality calculated with indirect standardization are properly used to compare a given program's observed results with what would have been expected if patients with a similar case mix to theirs had been cared for by an average provider in the reference population (eg, the STS CHSD) [33] .
Another theoretical concern regarding indirectly standardized results is related to Simpson's paradox, in which results may appear different when presented overall versus by subgroups (eg, year, acuity, procedure type) [34, 35] . In the case of programs that care for a disproportionate number of very high risk patients, this effect can either make their overall results appear worse or better than they are when viewed at the subgroup level (eg, a "high risk" category). In practice, Simpson's paradox is only likely to have an important effect when certain conditions are met (eg, high mortality rates; large differences in observed versus expected mortality and in the proportion of high risk cases cared for by the programs being compared) [34] [35] [36] . Presentation of results stratified by STAT category should also help to mitigate the potential for this to occur.
When publicly reporting outcomes for centers participating in STS CHSD voluntary public reporting, the STS reports the data with varying levels of granularity, ranging from point estimates with confidence interval for statistically sophisticated users to star ratings (based on the work of Professor Judith Hibbard [10, [37] [38] [39] [40] [41] ) that assist patients and families in correctly interpreting complex data. In the STS CHSD, the overall star rating of a given STS CHSD participant is based on their overall risk-adjusted O/E operative morality ratio for all cardiovascular surgical patients, using the 2014 STS CHSD Mortality Risk Model. Centers are classified into three categories based on their overall O/E risk-adjusted operative morality ratio: (1) one star, higher than expected operative mortality (95% CI for their risk-adjusted O/E mortality ratio was entirely above 1); (2) two star, same as expected operative mortality (95% CI for their risk-adjusted O/E mortality ratio overlapped 1); and (3) three star, lower than expected operative mortality (95% CI for their risk-adjusted O/E mortality ratio was entirely below 1).
Examples of star rating and 95% CI are provided in Table 7 . The star rating designations are determined using the 95% CI of a center's overall risk-adjusted O/E operative morality ratio for all cardiovascular surgical patients. Table 8 documents the distribution of star ratings for the Fall 2014, Spring 2015, and Fall 2015 STS CHSD Feedback Reports. The star ratings were first publicly reported in August 2015 based on the Spring 2015 STS CHSD Feedback Report. The next update to the publicly reported star ratings will be in August 2016 based on the Spring 2016 STS CHSD Feedback Report. (The final appearance of these publicly reported data can be viewed at http://www.sts.org/quality-researchpatient-safety/sts-public-reporting-online.)
Based on the data that are publicly reported or provided in the STS CHSD Feedback Reports (ie, point estimates with CI), it is possible to determine the star rating of an individual program simply by examining the 95% CI of a center's overall risk-adjusted O/E operative morality ratio for all cardiovascular surgical patients and comparing this CI of the O/E operative morality ratio to unity (the number 1). By providing the star rating, this statistical analysis becomes more accessible and understandable for patients and families [10, [37] [38] [39] [40] [41] .
Round 1 of voluntary public reporting from the STS CHSD was published in January 2015, based on the STS CHSD 2014 Fall Harvest and Feedback Report. Round 1 only publicly reported point estimates with confidence interval, and did not publicly report star ratings. In round 1, 25 participants in STS CHSD consented to participate and were enrolled in public reporting, out of 109 participating programs in the United States at that time (23% of US participants in STS CHSD). However, in round 1, although 25 participants in the STS CHSD were enrolled in public reporting, only 19 participants actually publicly reported their data at that time because 6 participants who consented to publicly report had incomplete data and, therefore, ultimately could not publicly report.
Round 2 of voluntary public reporting from the STS CHSD was published in August 2015, based on the STS CHSD 2015 Spring Harvest and Feedback Report. Round 2 was the first time that the STS CHSD publicly reported star ratings along with the previously reported point estimates with CI. In round 2, 38 STS CHSD participants consented to participate and were enrolled in public reporting, out of 110 participating programs in the United States at that time (35% of US participants in STS CHSD). However, in round 1, although 38 participants in the STS CHSD were enrolled in public reporting, only 33 participants actually publicly reported their data at that time. Based on data from operations performed in the 4year analytic window January 1, 2011, to December 31, 2014, the STS CHSD 2015 Spring Harvest and Feedback Report documented 11 one-star programs, 79 two-star programs, 6 three-star programs, and 20 programs that had no star rating because of incomplete data. (Three participants appear twice in this listing because they are associated with more than one participant identification number.) In round 2 of voluntary public reporting from the STS CHSD, 0 of 11 one-star programs publicly reported, 27 of 79 two-star programs publicly reported, and 5 of 6 three-star programs publicly reported. One of the reasons cited by programs for not participating in public reporting is collection of incomplete or inaccurate data related to the risk factors listed in Table 5 , which could lead to inaccurate estimation of expected mortality.
As of January 6, 2016, 43 participants in the STS CHSD have consented to participate in voluntary public reporting, out of 112 participating programs in the United States (38% of US participants in STS CHSD). Round 3 of voluntary public reporting from the STS CHSD will be published in August 2016, based on the STS CHSD 2016 Spring Harvest and Feedback Report using data from operations performed in the 4-year analytic window January 1, 2012, to December 31, 2015.
Upcoming Activities Involving STS CHSD
In 2015, the STS CHSD completed its latest periodic revision of data specifications, and this upgraded version of STS CHSD was implemented on January 1, 2016. In 2016, the STS CHSD Task Force and the STS Quality Measurement Task Force will collaborate on two initiatives: (1) refining risk adjustment for chromosomal abnormalities, syndromes, and noncardiac congenital anatomic abnormalities and enhancing the 2014 STS 
CHSD Mortality Risk Model with this information; and
(2) studying the relationship between volume (both programmatic volume and surgeon volume) and outcome using the enhanced 2014 STS CHSD Mortality Risk Model. Strategies for assessing outcomes of pediatric and congenital cardiac surgery continue to evolve [15] [16] [17] . Efforts are under way to expand the range of outcomes analyzed, with future emphasis on morbidity (including complications and postoperative length of stay) [42] , long-term outcomes, and costs [43] [44] [45] [46] , which, combined with risk-adjusted clinical outcomes, will begin to address the important endpoint of value [47] . An article and an accompanying editorial, published in the January issue of World Journal for Pediatric and Congenital Heart Surgery, emphasize and explain to surgeons and their data managers the critical importance of accurate and complete submission of data about risk factors to facilitate meaningful calculation of the O/E mortality ratio on which the publicly reported star rating is based [48, 49] .
In the future, when models have been developed that encompass other outcomes in addition to mortality, it may be possible to assess pediatric and congenital cardiac surgical performance using a multidomain composite metric that incorporates both mortality and morbidity, adjusting for the operation performed and for patientspecific factors. It is our expectation that, in the future, this information will also be publicly reported.
The development of this multidomain composite metric is funded through an R01 grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health entitled: "Understanding Quality and Costs in Congenital Heart Surgery" (R01 HL122261). The period of award for this grant is April 1, 2014, through March 31, 2019. The Principal Investigator is Sara K. Pasquali, MD, MHS, and the STS Principal Investigator is Jeffrey P. Jacobs, MD. The grant involves a collaboration with Children's Hospital Association and will merge clinical data from the STS CHSD with data about utilization of resources from the Pediatric Health Information Systems Database. The specific aims of this R01 grant are (1) aim 1, to develop and validate a composite quality metric in congenital heart surgery; and (2) aim 2, to examine the relationship between our composite measure of quality and cost.
Under the direction of the International Society for Nomenclature of Pediatric and Congenital Heart Disease, several members of the STS CHSD are participating in the development of the codes and definitions for the component of the 11th revision of the International Classification of Diseases (ICD-11) dedicated to pediatric and congenital cardiac care. These new ICD-11 codes for pediatric and congenital cardiac care will be identical in both ICD and IPCCC, assuring that for the first time, in the domain of pediatric and congenital cardiac care, the nomenclature used in administrative claims data will be the same as the nomenclature in clinical registries [50] [51] [52] [53] [54] . In collaboration with the STS Adult Cardiac Surgery Database Task Force, the STS CHSD Task Force will continue to explore the potential to automatically extract certain data elements directly from electronic health records, while requiring the same high accuracy and integrity of current data entry approaches [55] . Finally, the STS Task Force on Quality Initiatives is exploring the possibility of offering a broad range of quality improvement opportunities to programs that might desire them. Although these opportunities might initially be piloted using the STS Adult Cardiac Surgery Database, the potential exists for extension into the STS CHSD and STS General Thoracic Surgery Database.
Summary
In the monthly STS National Database series of scholarly articles on outcomes analysis, quality improvement, and patient safety, this is the first article that focuses specifically on the STS CHSD. This article summarizes current national aggregate outcomes of congenital and pediatric cardiac surgery and reviews all quality measurement and improvement initiatives over the past 12 months related to the STS CHSD. Six months after the publication of this article, as part of this monthly series, The Annals of Thoracic Surgery will publish a second article derived from the STS CHSD, with this second article summarizing all research-related manuscripts published from the STS CHSD over the past 12 months, along with an update on funded research grants and grant proposals from STS CHSD. All participants in the STS CHSD can access data from it for research or quality improvement initiatives. (A detailed description of how to access data from the STS national database is available at http://www.sts.org/ quality-research-patient-safety/research/publications-andresearch/access-data-sts-national-database.)
The current national aggregate congenital and pediatric cardiac surgical outcomes described in this article can serve as a platform for benchmarking performance and improving quality. These activities of outcomes analysis and quality improvement will ultimately allow congenital and pediatric cardiac surgeons to provide better care for our patients.
